Lobuläre Neoplasie und invasives lobuläres Mammakarzinom

Andersen JA (1974) Lobular carcinoma in situ. A long-term follow-up in 52 cases. Acta Pathol Microbiol Scand A 82:519–533 Anderson WF, Pfeiffer RM, Dores GM et al (2006) Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 15:1899–1905 Aulmann S, Penzel R, Longerich T et al (2008) Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer. Breast Cancer Res Treat 107:331–335 Bagaria SP, Shamonki J, Kinnaird M et al (2011) The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma? Ann Surg Oncol 18:1845–1851 Bertucci F, Orsetti B, Negre V et al (2008) Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles. Oncogene 27:5359–5372 Borst MJ, Ingold JA (1993) Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 114:637–641 Bratthauer GL, Tavassoli FA (2002) Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 440:134–138 Brogi E, Murray MP, Corben AD (2010) Lobular carcinoma, not only a classic. Breast J 16(Suppl 1):S10–S14 Chen YY, Hwang ES, Roy R et al (2009) Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol 33:1683–1694 Choi YJ, Pinto MM, Hao L et al (2008) Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma. Mod Pathol 21:1224–1237 Christgen M, Noskowicz M, Schipper E et al (2013) Oncogenic PIK3CA mutations in lobular breast cancer progression. Genes Chromosomes Cancer 52:69–80 Claus EB, Stowe M, Carter D et al (2003) The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry. Breast 12:451–456 Coopey SB, Mazzola E, Buckley JM et al (2012) The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat 136:627–633 Da Silva L, Parry S, Reid L et al (2008) Aberrant expression of E-cadherin in lobular carcinomas of the breast. Am J Surg Pathol 32:773–783 Dabbs DJ, Bhargava R, Chivukula M (2007) Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol 31:427–437 Dabbs DJ, Schnitt SJ, Geyer FC et al (2013) Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Am J Surg Pathol 37:e1–e11 Ellis IO, Galea M, Broughton N et al (1992) Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20:479–489 Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410 Esposito NN, Chivukula M, Dabbs DJ (2007) The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study. Mod Pathol 20:130–138 Flagiello D, Gerbault-Seureau M, Sastre-Garau X et al (1998) Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer. Genes Chromosomes Cancer 23:300–306 Foote FW Jr, Stewart FW (1946) A histologic classification of carcinoma of the breast. Surgery 19:74–99 Foote FW, Stewart FW (1941) Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol 17:491–495 Frolik D, Caduff R, Varga Z (2001) Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas. Histopathology 39:503–513 Green I, Mccormick B, Cranor M et al (1997) A comparative study of pure tubular and tubulolobular carcinoma of the breast. Am J Surg Pathol 21:653–657 Gruel N, Lucchesi C, Raynal V et al (2010) Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma. Eur J Cancer 46:2399–2407 Haagensen CD, Lane N, Lattes R et al (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737–769 Hanby A, Hughes T (2008) In situ and invasive lobular neoplasia of the breast. Histopathology 52:58–66 Harris M, Howell A, Chrissohou M et al (1984) A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 50:23–30 Hilleren DJ, Andersson IT, Lindholm K et al (1991) Invasive lobular carcinoma: mammographic findings in a 10-year experience. Radiology 178:149–154 Houssami N, Turner R, Morrow M (2013) Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg 257:249–255 Hussain M, Cunnick GH (2011) Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast – a review. Eur J Surg Oncol 37:279–289 Hwang E, Nyante S, Yi Chen Y et al (2004) Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 100:2562–2572 Iorfida M, Maiorano E, Orvieto E et al (2012) Invasive lobular breast cancer: subtypes and outcome. Breast Cancer Res Treat 133:713–723 Jain S, Fisher C, Smith P et al (1993) Patterns of metastatic breast cancer in relation to histological type. Eur J Cancer 29A:2155–2157 Kramer R, Brown P (2004) Should tamoxifen be used in breast cancer prevention? Drug Saf 27:979–989 Kuroda H, Tamaru J, Takeuchi I et al (2006) Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast. Virchows Arch 448:500–505 Lakhani SR, Ellis I, Schnitt S et al (2012) WHO classification of tumours of the breast. IARC Press, Lyon Lewis JL, Lee DY, Tartter PI (2012) The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast. Ann Surg Oncol 19:4124–4128 Li CI, Anderson BO, Daling JR et al (2002) Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat 75:259–268 Li CI, Uribe DJ, Daling JR (2005) Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93:1046–1052 Mann RM, Veltman J, Barentsz JO et al (2008) The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast. Eur J Surg Oncol 34:135–142 Marchio C, Sapino A, Arisio R et al (2006) A new vision of tubular and tubulo-lobular carcinomas of the breast, as revealed by 3-D modelling. Histopathology 48:556–562 Masannat YA, Bains SK, Pinder SE et al (2013) Challenges in the management of pleomorphic lobular carcinoma in situ of the breast. Breast 22:194–196 Middleton LP, Palacios DM, Bryant BR et al (2000) Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 24:1650–1656 Mitze M, Meyer F, Goepel E et al (1991) Besonderheiten in Klinik und Verlauf beim invasiven lobulären Mammakarzinom. Geburtshilfe Frauenheilkd 51:973–979 Moatamed NA, Apple SK (2006) Extensive sampling changes T-staging of infiltrating lobular carcinoma of breast: a comparative study of gross versus microscopic tumor sizes. Breast J 12:511–517 Monhollen L, Morrison C, Ademuyiwa FO et al (2012) Pleomorphic lobular carcinoma: a distinctive clinical and molecular breast cancer type. Histopathology 61:365–377 Murray MP, Luedtke C, Liberman L et al (2013) Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision. Cancer 119:1073–1079 Newstead GM, Baute PB, Toth HK (1992) Invasive lobular and ductal carcinoma: mammographic findings and stage at diagnosis. Radiology 184:623–627 Nishizaki T, Chew K, Chu L et al (1997) Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 74:513–517 Oppong BA, King TA (2011) Recommendations for women with lobular carcinoma in situ (LCIS). Oncology (Williston Park) 25:1051–1056, 1058 Orvieto E, Maiorano E, Bottiglieri L et al (2008) Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution. Cancer 113:1511–1520 Ottesen GL, Graversen HP, Blichert-Toft M et al (1993) Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 17:14–21 Page DL, Kidd TE Jr, Dupont WD et al (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22:1232–1239 Page DL, Schuyler PA, Dupont WD et al (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361:125–129 Pereira H, Pinder SE, Sibbering DM et al (1995) Pathological prognostic factors in breast cancer. IV: should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 27:219–226 Pestalozzi BC, Zahrieh D, Mallon E et al (2008) Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol 26:3006–3014 Qureshi HS, Linden MD, Divine G et al (2006) E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters. Am J Clin Pathol 125:377–385 Rakha EA, El-Sayed ME, Menon S et al (2008) Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 111:121–127 Rakha EA, El-Sayed ME, Powe DG et al (2008) Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Eur J Cancer 44:73–83 Reis-Filho JS, Simpson PT, Jones C et al (2005) Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol 207:1–13 Rosen P, Kosloff C, Lieberman P et al (1978) Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2:225–251 Ross DS, Hoda SA (2011) Microinvasive (T1mic) lobular carcinoma of the breast: clinicopathologic profile of 16 cases. Am J Surg Pathol 35:750–756 Sakr RA, Poulet B, Kaufman GJ et al (2011) Clear margins for invasive lobular carcinoma: a surgical challenge. Eur J Surg Oncol 37:350–356 Sastre-Garau X, Jouve M, Asselain B et al (1996) Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 77:113–120 Shin SJ, Lal A, De Vries S et al (2013) Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ. Hum Pathol 44:1998–2009 Silverstein MJ, Lewinsky BS, Waisman JR et al (1994) Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 73:1673–1677 Simcha I, Shtutman M, Salomon D et al (1998) Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin. J Cell Biol 141:1433–1448 Sinn HP, Helmchen B, Aulmann S (2006) Konzept und Problematik der lobularen Neoplasie. Pathologe 27:373–380 Sinn HP, Kellerhoff NM, Kellerhoff R et al (1997) Subtypisierung und Prognoseabschätzung beim invasiven lobulären Mammakarzinom. Pathologe 18:37–44 Slanger TE, Chang-Claude JC, Obi N et al (2009) Menopausal hormone therapy and risk of clinical breast cancer subtypes. Cancer Epidemiol Biomarkers Prev 18:1188–1196 Talman ML, Jensen MB, Rank F (2007) Invasive lobular breast cancer. Prognostic significance of histological malignancy grading. Acta Oncol 46:803–809 Toikkanen S, Pylkkanen L, Joensuu H (1997) Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer 76:1234–1240 Turnbull L, Brown S, Harvey I et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375:563–571 Vos CB, Cleton-Jansen AM, Berx G et al (1997) E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 76:1131–1133 Wachtel MS, Halldorsson A, Dissanaike S (2011) Nottingham grades of lobular carcinoma lack the prognostic implications they bear for ductal carcinoma. J Surg Res 166:19–27 Wasif N, Maggard MA, Ko CY et al (2010) Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes. Ann Surg Oncol 17:1862–1869 Weinstein SP, Orel SG, Heller R et al (2001) MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol 176:399–406 Wheeler DT, Tai LH, Bratthauer GL et al (2004) Tubulolobular carcinoma of the breast: an analysis of 27 cases of a tumor with a hybrid morphology and immunoprofile. Am J Surg Pathol 28:1587–1593 Winchester DJ, Chang HR, Graves TA et al (1998) A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J Am Coll Surg 186:416–422